Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam Besylate for Injection for Colonoscopy Sedation
CTR20223425Phase 4Completed
- Sponsor
- Yichang Humanwell Pharmaceutical Co., Ltd.
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of remimazolam in procedure-related anxiety and discomfort (PRAD), sponsored by Yichang Humanwell Pharmaceutical Co., Ltd.. Started Dec 2022; status: completed.
02
Drugs
remimazolam
03
Conditions
procedure-related anxiety and discomfort (PRAD)
Beyond the preview
Go deeper on CTR20223425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20223425.